Industry Conference

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

A new AI system deters birds to prevent avian flu. But its real innovation lies in data, transforming biosecurity from a costly chore into a profitable investment.

Beyond the runway hype, AI is now a core driver of commerce. But does it level the playing field or just raise the stakes for everyone involved?

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

United Imaging Intelligence's new AI agents can reason, act, and report. But are hospitals ready for the business and ethical hurdles of this new era?

A Chinese eco-tech firm is betting on India's infrastructure boom. Can its waste-to-value solutions capture a piece of this massive, competitive market?

atNorth's award-winning ICE03 facility isn't just a data center; it's a holistic model integrating green tech, circular economies, and community growth.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

Austria’s famed Flying Bulls bring two historic aircraft to the US for one show only. A deep dive into the business of heritage and a transatlantic feat.

At the Asian Youth Para Games, advanced robots are not just performers; they are assistants, companions, and a glimpse into a more accessible future.

Massimo Group's new HVAC-equipped electric utility vehicles are more than a comfort upgrade; they represent a strategic bid for the lucrative commercial fleet market.

After a decade of failed trials, a new drug shows promise in treating resistant lung cancer by reawakening the immune system and halting its spread.

CEAT Specialty's new OTR tyre isn't just rubber—it's a strategic play for India's trillion-dollar infrastructure push, blending tech and market savvy.

Natera's Signatera test salvaged key insights from a failed clinical trial, creating a new roadmap for personalized breast cancer treatment and logistics.

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

A major tech conference highlights a critical global skills gap in AI and security. Is Canadian policy ready for the infrastructure of tomorrow?

Beyond the dazzling lights, Seattle's iconic New Year's Eve show is a calculated investment in branding, technology, and regional economic dominance.

Helium's decentralized wireless network is expanding to Brazil, testing a "people-powered" model to bridge the digital divide. Can it disrupt big telco?

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.